v3.26.1
Condensed Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive (Loss) Income
Accumulated Deficit
Beginning Balance at Dec. 31, 2024 $ 420,047 $ 44 $ 538,321 $ 56 $ (118,374)
Beginning Balance (in shares) at Dec. 31, 2024   44,422,505      
Issuance of common stock upon exercise of stock options 66   66    
Issuance of common stock upon exercise of stock options (in shares)   25,930      
Vesting of restricted common stock 5   5    
Stock-based compensation expense 1,482   1,482    
Net unrealized gain (loss) on marketable securities 142     142  
Net loss (21,476)       (21,476)
Ending Balance at Mar. 31, 2025 (400,266) $ 44 539,874 198 (139,850)
Ending Balance (in shares) at Mar. 31, 2025   44,448,435      
Beginning Balance at Dec. 31, 2025 381,926 $ 45 548,517 617 (167,253)
Beginning Balance (in shares) at Dec. 31, 2025   44,806,272      
Issuance of common stock upon exercise of stock options 335   335    
Issuance of common stock upon exercise of stock options (in shares)   110,300      
Vesting of restricted common stock 5   5    
Stock-based compensation expense 6,015   6,015    
Net unrealized gain (loss) on marketable securities (1,186)     (1,186)  
Net loss (8,637)       (8,637)
Ending Balance at Mar. 31, 2026 $ 378,458 $ 45 $ 554,872 $ (569) $ (175,890)
Ending Balance (in shares) at Mar. 31, 2026   44,916,572